LifeStance Health Group, Inc.
NASDAQ•LFST
CEO: Mr. Kenneth Alan Burdick
Sector: Healthcare
Industry: Medical - Care Facilities
Listing Date: 2021-06-10
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.
Contact Information
4800 North Scottsdale Road, Suite 2300, Scottsdale, AZ, 85251, United States
602-767-2100
Market Cap
$2.47B
P/E (TTM)
252.9
54.1
Dividend Yield
--
52W High
$8.09
52W Low
$3.74
52W Range
Rank63Top 94.0%
1.8
F-Score
Modified Piotroski Analysis
Based on 6-year fundamentals
Weak • 1.8 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2020-2025
Financial Dashboard
Q4 2025 Data
Revenue
$382.20M+0.00%
4-Quarter Trend
EPS
$0.03+0.00%
4-Quarter Trend
FCF
$82.77M+0.00%
4-Quarter Trend
2025 Annual Earnings Highlights
Key Highlights
Revenue Grows 14% Total revenue reached $1.424B USD, marking 14% growth driven by 1.1 million more patient visits.
Return to Net Income Profit Achieved $9.7M USD net income in 2025, reversing prior year's $57.4M USD net loss.
Platform Scale Expansion Platform scale expanded, treating over 1.0 million unique patients across 9.0 million visits in 2025.
Center Margin Improvement Center Margin increased to $461.1M USD, reflecting better control over direct patient care costs.
Risk Factors
Payor Reimbursement Rate Risk Reduced reimbursement rates from payors, especially UnitedHealthcare (14%) and Elevance (15%), could harm financial condition.
Internal Control Material Weaknesses Material weaknesses exist in accounting policies and IT general controls; remediation efforts are ongoing as of year-end.
Clinician Labor Cost Pressure Recruiting and retaining 8,040 clinicians experienced increased labor costs, potentially reducing profitability going forward.
Regulatory Compliance Complexity Heavy federal and state regulation, including HIPAA and Stark Law, requires constant monitoring and compliance spending.
Outlook
Drive Organic Capacity Growth Strategy focuses on growing clinician base via in-house recruiting model and opening new centers strategically.
Optimize Real Estate Footprint Prioritizing resources, company completed significant reduction in physical space following shift to more virtual visits.
Enhance Integrated Care Model Plan to deepen partnerships with primary care and specialty providers to drive integrated care delivery.
Manage Debt Obligations $282.8M USD debt outstanding requires cash flow management; refinancing terms remain uncertain for future needs.
Peer Comparison
Revenue (TTM)
$6.32B
$5.45B
$3.31B
Gross Margin (Latest Quarter)
165.5%
96.2%
71.7%
Key Metrics
Symbol | Market Cap | P/E (TTM) | ROE (TTM) | Debt to Assets |
|---|---|---|---|---|
| BKD | $3.31B | -12.4 | -523.8% | 112.0% |
| NHC | $2.51B | 20.8 | 11.6% | 5.7% |
| LFST | $2.47B | 252.9 | 0.7% | 8.8% |
Long-Term Trends
Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
4.7%
Moderate Growth
4Q Net Income CAGR
154.4%
Profitability Improved
Cash Flow Stability
75%
Volatile Cash Flow
Deep Research
Next earnings:May 6, 2026
EPS:$0.01
|Revenue:$386.11M
Financials
Earnings Calls
Reports
News
Income Statement
Balance Sheet
Cash Flow Statement
Ratios
% Chg.
Income Statement | LTM |
|---|
No Data